Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Update Gastroenterology

Early detection and treatment of opioid-induced constipation

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • RX
    • Studies
  • 3 minute read

Opioids are an important component of therapy for severe chronic pain. Despite their good efficacy and lack of toxicity to internal organs, treatment is often discontinued due to undesirable side effects. One of these is opioid-induced constipation (OIC), which is often difficult to treat. In laxative-refractory OIC, µ-opioid receptor antagonists (“peripherally acting µ-opioid receptor antagonists”, PAMORAs) may provide relief.

Many patients rely on potent opioids for effective pain relief, but it is not uncommon to experience gastrointestinal side effects. Opioid-induced constipation (OIC) is a common side effect of opioid therapy. It is a particular form of constipation caused by the activation of µ-opioid receptors in the intestine. The affected patients suffer from a significant reduction in quality of life. Low stool frequency (<3x/week), hard stools, inappetence, nausea, vomiting and flatulence are among the typical symptoms of OIC. These are so distressing for many patients that they reduce their opioid dose or even discontinue therapy altogether. To improve patient quality of life and maintain adequate analgesia, early diagnosis of OIC is central. This requires a careful stool anamnesis and active inquiries on the part of the physician. The practical recommendations for action of the German Society for Pain Medicine appeared in 2019 in an updated version [1]. This proposed the use of the Bowel Function Index (BFI) as a simple tool to assess bowel function from the patient’s perspective (box).

 

 

Macrogol as first-choice laxative

Conventional laxatives still count internationally as first-line therapy for the treatment of OIC. However, these do not bring satisfactory treatment success in about half of those affected. This can be explained by the nonspecific mechanism of action, which in OIC is outweighed by the specific effects of opioids on the autonomic enteric nervous system. The guideline recommends that patients be prescribed macrogol (polyethylene glycol) along with opioids as a concomitant medication early in therapy. In a randomized trial, macrogol was shown to be superior to placebo in the treatment of methadone-induced constipation [2]. Other conventional laxatives used in OIC include bisacodyl, sodium picosulfate, and senna preparations. Response to a laxative varies interindividually. If the use of an active substance – if necessary in an adjusted dosage – proves not to be effective, it is advisable to switch to a different class of active substance.

 

 

Treat laxative-refractory OIC with PAMORA.

If conventional laxatives do not result in significant improvement in OIC (e.g., BFI >28.8 mm VAS, and/or decrease <12 mmVAS, etc.), the guideline suggests treatment with a peripherally acting µ-opioid receptor antagonist (PAMORAs). PAMORAs such as naloxegol, methylnaltrexone and naldemedine significantly alleviate the symptoms of OIC according to placebo-controlled clinical studies and were found to be well tolerated. PAMORAs exert their effect by blocking the peripheral µ-opioid receptors. As PAMORAs do not cross the (intact) blood-liquor barrier due to their molecular structure, there are no central effects, so that there is no measurable impairment of the analgesic effect of the opioids, as has been demonstrated in clinical studies [1]. “The extent to which peripherally mediated analgesic effects of opioids that are necessary in specific individual cases can nevertheless be prevented by PAMORA is currently under discussion,” the guideline authors said. The risk is low, but cannot be completely ruled out, he said.

 

 

In individual cases in which monotherapy is insufficiently effective and if the use of peripherally acting µ-opioid receptor antagonists (PAMORAs) is not an option, a combination of preparations with different modes of action may be considered for the treatment of opioid-induced constipation. Good combinations are, for example, macrogol (polyethylene glycol) and the hydragogic laxative bisacodyl.

 

Literature:

  1. DGS Practice Guideline: Opioid-Induced Constipation, 2019, https://dgs-praxisleitlinien.de/opioidinduzierte-obstipation (last accessed May 31, 2021).
  2. Freedman MD, et al: Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate-induced constipation: a double-blinded placebo-controlled trial. J Clin Pharmacol 1997; 37(10): 904-907.
  3. Swissmedic: Expert information Moventig®; www.swissmedicinfo.ch (last accessed 31.05.2021)
  4. Chey WD, et al: Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med 2014; 370: 2387-2396.
  5. Nelson AD, Camilleri M. Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis 2016; 7(2): 121-134.
  6. Argoff CE, et al: Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation. Pain Med 2015; 16(12): 2324-2337.

 

Further reading:

  • Farmer AD, et al: Lancet Gastroenterol Hepatol. 2018; 3(3): 203-212.
  • Murphy JA, Sheridan EA: Ann Pharmacotherapy 2018; 52(4): 370-379.
  • Sridharan K, Sivaramakrishnan G: J Pain and Symptom Manage 2018; 55: 468-479.

 

HAUSARZT PRAXIS 2021; 16(6): 22-24

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Constipation
Previous Article
  • Chronic spontaneous urticaria (csU)

Effectively treating wheals and angioedema – a practice-based update.

  • Allergology and clinical immunology
  • Congress Reports
  • Dermatology and venereology
  • RX
View Post
Next Article
  • Supraventricular tachycardias

ECG interpretation in SVT

  • Cardiology
  • CME continuing education
  • Education
  • RX
View Post
You May Also Like
View Post
  • 6 min
  • Chronic musculoskeletal pain

How can the use of analgesics be optimized in multimodal therapy?

    • Congress Reports
    • General Internal Medicine
    • Orthopedics
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • Interview with Prof. Thomas Kündig (USZ)

“If we control itching and eczema, a normal life is possible again”

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Interviews
    • Partner Content
    • RX
View Post
  • 3 min
  • From symptom to diagnosis

Abdominal pain – groin pain: internal causes

    • Cases
    • Education
    • Gynecology
    • Radiology
    • RX
    • Surgery
    • Urology
View Post
  • 2 min
  • Chronic pain

Nano-ECS modulator Adezunap improves therapy success

    • Congress Reports
    • General Internal Medicine
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Rheumatology
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis and PsA

Biologics, oral peptide and trivalent nanobody – current results and trends

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Cancer in Europe: facts and analysis

New Health Policy Report published

    • General Internal Medicine
    • Oncology
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 4 min
  • Gastrointestinal complaints

PPI regulation under the microscope

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Wound management: clinical diagnostics

Assessing the risk of infection – from the ABCDE to the TILI score

    • Congress Reports
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Geriatrics
    • Infectiology
    • Interviews
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    How combination therapies lead to better treatment results
  • 2
    Interplay between cancer and mental illness
  • 3
    PH and lung diseases
  • 4
    Treatment of comorbidities in older people
  • 5
    Multidisciplinary teams in oncology

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.